This year’s top refractive surgery item was the announcement about the FDA approval of the STAAR Surgical EVO/EVO+ Visian ICL to treat myopia and myopia with astigmatism, complete with physician perspectives.
Read about this and other top refractive surgery stories from 2022 below.
FDA approves EVO Visian lens
A preoperative peripheral iridotomy, which was required with earlier versions of the Visian ICL, is not needed with the EVO. Read more.
Certain patients may be better suited for presbyopia drops
More options are on the way to treat patients with presbyopia, according to a presentation